La espironolactona como alternativa efectiva e infrautilizada en el tratamiento del acné en la mujer

• Morgado Carrasco, D. ^[1] ; Vargas Mora, P. ^[2] ; Piquero Casals, J. ^[3]
  1. [1] Hospital Clinic Barcelona

     Hospital Clinic Barcelona

     Barcelona, España

     
  2. [2] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
  3. [3] Dermik, Clínica Dermatológica Multidisciplinar, Barcelona, España

  Mostrar afiliaciones +
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 36, Nº. 1 (ENERO), 2021, págs. 40-45
• Idioma: español
• DOI: 10.1016/j.piel.2020.05.008
• Títulos paralelos:
  • Spironolactone as an effective and underused alternative in the treatment of female acne
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Bagatin E, De Freitas THP, Rivitti-Machado MC, et al. Adult female acne: a guide to clinical practice. An Bras Dermatol. 2019;94:62–75.
  • Rivera R, Guerra A. Management of acne in women over 25 years of age. Actas Dermosifiliogr. 2009;100:33–37.
  • Li DG, Pournamdari AB, Liu KJ, Laskowski K, Joyce C, Mostaghimi A. Evaluation of point-of-care decision support for adult acne treatment by...
  • Liu KJ, Hartman RI, Joyce C, Mostaghimi A. Modeling the effect of shared care to optimize acne referrals from primary care clinicians to dermatologists....
  • Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the global alliance to...
  • López-Estebaranz JL, Herranz-Pinto P, Dréno B, el grupo de dermatólogos expertos en acné. Consensus-based acne classification system and treatment...
  • Azarchi S, Bienenfeld A, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: hormone-modulating therapies for skin disease....
  • Salavastru CM, Fritz K, Tiplica GS. Spironolactone in dermatological treatment. On and off label indications. Der Hautarzt. 2013;64:762–767.
  • Wolverton S. Comprehensive Dermatologic Drug Therapy. 3rd ed. Philadelphia: Elsevier Saunders; 2013.
  • Krunic A, Ciurea A, Scheman A. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing...
  • Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients....
  • Yemisci A, Gorgulu A, Piskin S. Effects and side-effects of spironolactone therapy in women with acne. J Eur Acad Dermatol Venereol JEADV....
  • Sato K, Matsumoto D, Iizuka F, et al. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians. Aesthetic Plast Surg....
  • Grandhi R, Alikhan A. Spironolactone for the treatment of acne: a 4-year retrospective study. Dermatol Basel Switz. 2017; 233:141–144.
  • Charny JW, Choi JK, James WD. Spironolactone for the treatment of acne in women, a retrospective study of 110 patients. Int J Womens Dermatol....
  • Isvy-Joubert A, Nguyen J-M, Gaultier A, et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur...
  • Park JH, Bienenfeld A, Orlow SJ, Nagler AR. The use of hormonal antiandrogen therapy in female patients with acne: a 10-year retrospective...
  • Barbieri JS, Choi JK, Mitra N, Margolis DJ. Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics...
  • Roberts EE, Nowsheen S, Davis MDP, et al. Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic,...
  • Goodfellow A, Alaghband-Zadeh J, Carter G, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol. 1984;111:209–214.
  • Muhlemann MF, Carter GD, Cream JJ, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol. 1986;115:227–232.
  • Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne vulgaris: practical considerations for the clinician based...
  • Barbieri JS, Choi JK, James WD, Margolis DJ. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of...
  • Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945–973.e33.
  • Barbieri JS, James WD, Margolis DJ. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and...
  • Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid...
  • Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical...
  • Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA...
  • Thiede RM, Rastogi S, Nardone B, et al. Hyperkalemia in women with acne exposed to oral spironolactone: a retrospective study from the RADAR...
  • Liszewski W, Boull C. Lack of evidence for feminization of males exposed to spironolactone in utero: a systematic review. J Am Acad Dermatol....
  • Mackenzie IS, Macdonald TM, Thompson A, Morant S, Wei L. Spironolactone and risk of incident breast cancer in women older than 55 years: study....
  • Biggar RJ, Andersen EW, Wohlfahrt J, Melbye M. Spironolactone use and the risk of breast and gynecologic cancers. Cancer Epidemiol. 2013;37:870–875.
  • Mackenzie IS, Morant SV, Wei L, Thompson AM, MacDonald TM. Spironolactone use and risk of incident cancers: a retrospective, matched cohort...
  • Dréno B, Bissonnette R, Gagné-Henley A, et al. Long-term effectiveness and safety of up to 48 weeks' treatment with topical Adapalene...
  • Tan J, Tanghetti E, Baldwin H, Stein Gold L, Lain E. The role of topical retinoids in prevention and treatment of atrophic acne scarring:...
  • Sardana K, Bansal P, Sharma LK, Garga UC, Vats G. A study comparing the clinical and hormonal profile of late onset and persistent acne in...
  • Dréno B, Layton A, Zouboulis CC, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol JEADV. 2013;27: 1063–1070.